Genetic Pools

News relating to the Human Genome Project has been covered by The Scientist in many issues. I would like to respond that it is of more than passing interest to some of us that other "genomic" problems fail to interest the scientific policymakers. As E.O. Wilson has shown (Issues in Science and Technology, 2(1):20-9, 1985), the great preponderance of living species is undescribed. Their total genomic diversity will be lost forever in the next few years as tropical habitats are destroyed through

Written byPeter Baker
| 1 min read

Register for free to listen to this article
Listen with Speechify
0:00
1:00
Share

As E.O. Wilson has shown (Issues in Science and Technology, 2(1):20-9, 1985), the great preponderance of living species is undescribed. Their total genomic diversity will be lost forever in the next few years as tropical habitats are destroyed through human activity. At the same time, the National Seed Storage Laboratory collection is slowly dying away through financial neglect (P. Raeborn, Issues in Science and Technology, 6(2):71-6, 1989-90). While these irreplaceable pools of genetic diversity are being allowed to expire, the advocates of the Human Genome Project continue to consume ever-increasing amounts of money in pursuit of a questionable goal.

The human genome will be around for a long, long time. It is not in danger of loss or extinction. Must we, in our arrogance, ignore the greater genetic pool out there and focus our treasure and interest inward upon ourselves alone?

PETER C. BAKER
Professor of Biology
Cleveland State University

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Related Topics

Meet the Author

Published In

Share
Image of a man in a laboratory looking frustrated with his failed experiment.
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies